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Although the etiology ofRA is still unknown, the associa-
tion












between DR4 and RA is also reported in many other ethnic groups,
such





this report, we have focused on the 0 chain sequence of the DR4 molecule and
investigated




of the HLA-DR a (DRB) gene in human genomic DNA was amplified in
vitro
and then the sequence variation was analyzed with synthetic oligonucleotide
probes.




comparison of the published sequences of DRB alleles in relation to RA suscepti-
bility
enabled us to deduce a putative consensus sequence that contributes to RA
susceptibility.
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were 31 unrelated Japanese suffering from RA
.
Controls were 33 ran-
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Amino acid sequences of the first domain of the HLA-DRB1 chain. The numbers
above the sequence refer to the positions ofthe amino acid. A period indicates identity with the
DRl sequence. Blanks indicate that no sequence information is available. Thereferences of the
sequences are as follows: DR4/Dw13 from Cairns et al. (22); DR4/Dw15 from Gregersen et al.
(23); DRw10from Merryman et al. (24); the others from Todd et al. (12) and references therein.
is found in DR4/Dw14, DR4/Dw15, and DRl alleles. Probe 4 is specific for DR4/Dw10 and
DRw13 specificities.
In Vitro DNA Amplification.
￿
In vitroDNAamplification wascarriedout by thepolymerase
chain reaction (PCR) method according to Saiki et al. (13) with minor modifications. 2 /4g
of genomic DNAs were dispensed in 100 pl of PCR mixture (50 mM Tris-HCI (pH 8.8 at
25°C), 10 MM MgC12, 10 mM ammonium sulfate, 1.5 mM of each dNTP, and 0.5 Rg of
each primer). 2.5 U ofTaq DNA polymerase (Stratagene, LaJolla, CA) and 40 14 of liquid
paraffin were addedto each sample. Then they were incubated at 65'C for 1.5 min, at 95°C
for 1 min, and at 55°C for 2 min. This cycle was repeated 25 times, then followed by an
additional incubation at 65°C for 5 min to complete the extension.
DotBlotting and Detection ofSpeck Sequences.
￿
Afterthecompletion ofthePCR amplification,
sampleswere mixedwith 1 ml of0.5 M NaCIH/25 mM EDTA. 200-ELI aliquots of the mixture
were blotted to a nylon filter (BioTrace RP, Gelman, Ann Arbor, MI) using a slot-blotter.
The hybridization was carried out at 46, 50, 55, and 60°C forprobes 1, 2, 3, and 4, respec-
tively. Filters were prehybridized in 5x SSPE (0.9 M NaCl, 0.05 M sodium biphosphate,
5 mM EDTA, pH 7.4), 5x Denhardt's solution (0.1% BSA, 0.1% Ficoll, 0.1% polyvinylpyr-
rolidone), 0.5% SDS for 1 h. The oligonucleotide probe (10 pmol) was Tend-labeled with
a-[32P]ddATP andhybridized with filters for another 1 h. Then the filters were washed twice
in 2x SSPE/0.5% SDS for 10 min and exposed with two intensifying screens at -70°C for
time periods from 1 h to overnight.
Results and Discussion
The analysis of PCR-amplifiedDNAsegments from 31 Japanese RA patients and
33 controls with four sequence-specific probes (Fig. 2) revealed that the frequency
* Amino acid position.
TABLE I
Synthesized Oligonucleotide Probes
10 20 30 40 50 60 70 80 90
DRl CDTRPRFLWQ LKFECHFFNC TERVRLLERC IYNQEFSVRF DSDVGEYRAV TEI.GRPDAEY WNSQKDLI.EQ RRAAVDTYCR HNYGVGF .SFI' VQRR
DR2/Dr2 . . . . . . . .Q . D.Y .. . . . . . . . ...F .H .D . . . . . .DL. . . . .. . . . . . . . . . . . . . . .. ... . . .F . .D . . .. ..... . . . . . . . . . . . . . . .
DR2/Di12 . . . . . . ..Q. D.Y . . . . . . . .. .F .H .G . . . . . .N . .. . . . . . . . . . . . . . . .. .... . . . . . .F . .D .. .... . . . . . . . . . . . .. .
DR2/Dr21 . . . . .c ..Q. D.Y . . . . . . . ..."F.H .G . . . . . .N . .. . . . . . . . . . . . . . . .. .... . . . . . .I . . : A..... . . . . . . . .AV. .. . . . . .
DR3 . . . . . . ..EY STS . . . . . .... .Y .D .Y FH . .N . .. .. . . . .F. . . . . . . . . .... . . . . . . . . . . K.GR..N . . . . . . . . V. .. . . . . .




. . . .. .. .F .D .Y F.L . .Y . . . .. .. . . . . . . . . . . . . . . .. . . . . . . . . . . K. .... .. . . . . . . . . . . . . . . . .
DR4/U+10 . . . . . . . .E . V.H . . . . . . . . . ...F .D .Y F.H . . .Y . . . .. .. . . . . . . . . . . . . .. .. . . . . . .I . .D E. .... .. . . . . . . .V . . . . . . . .
DR4/Dw13 . . . . . . . .E . V.H . . . . . . . ..F .D .Y F.H . . .Y . . . . . .. . . . . . . . . . . ...... . . . . . . . . . . . ..F:.... . . . . . . .V... . . . . .
DR4/DW14 . . . . . . ..E. V .H . . . . . . . ..
.. .
.. .F .D .Y F.N . . .Y .. . .. . . . . . . . . . . . . .... .. . . . . . . . . . . .... .. . . . . . . . . .V. .. . . . . .
DR4/Dv15 . . . . . . . .E. V .H . . . . . . . .... .F .D .Y F.H . . .Y . .. .. . . . . . . . . . . . . . .S. .. . . . . . . . . . . .... .. . . . . . . . . .. . .. . . . . .
DR 5 . . . . . . . .EY STS . . . . . . . . ....F .D .Y F. . . . . Y. .. .. . . . .F'. . . . . . . . ..E.. . . . . . .F . .D .... .. . . . . . . . . .. . . . . . . . .
DR .13 . . . . . . . .EY STS . . . . . . . . . ...F .D .Y FH . . . .N. . . .. . . . .F. . . . . . . . . .... . . . . . .I . .D F :. .... . . . . . . . . .V .. . . . . . .
DRvl4 . . .EY STS . . . . . . . . . .. .F .D .Y F'H. . . .Y. . . . . . . . . . . . . . . . . . .A .DD . . . . . . . . .R .. .E .. .. . . . . . . . V.. . . . . . .
DR7 . . .Q . . . . . . C.YK . . . . . . ....QF .. .L F. . . . .F. .. .. .. . . . . . . . . . . ..V ..S . . . . . .I . .D ..GQ...V . . . . . . ..... . . . . .
DRv8 . . . . . . . .EY STG . .Y . . . . .. .. .F .D .Y F. . . . . Y. . . . . . . . . . . . . . . . . .. S. . . . . . . . .F . .D ...1 .. . . . . . . . . . . .
DR9 K. D .. . . . . . . . .. .. .Y .H .G . . . . . .N. .. . . . . . . . . . . . . . . ..V ..S . . . . . .F . .R ...E .. .V . . . . . . . .
DRrl .
. : .I . . . .
. . . . . . . .EE V .. . . . . . . . . . .... . . .R VH . . . . YA .Y . . . . . . . . . . . . . . . . .... . . . . . . . . .R . ... . . . . . . . . . . . . . .. . . . . .
Probe Specificity Sequence aa*
1 DR4 5'-TACTTCTATCACCAAGAGGA-3' 30-36
2 DR4/Dw15, DRw8 5'-CGGCCTAGCGCCGAGTAC-3' 55-60
3 DR4/Dw14, DR4/Dw15, DR1 5'-GCAGAGGCGGGCCGCGGT-3' 70-74







Representative dot blot analysis ofsevenRA patients. A specific
segment of the HLA-DRB gene was amplified by thePCR method and
hybridized with four oligonucleotide probes.
of the sequence defined by probe 3 was significantly increased in the patients (Table
11) : 52% in patients while only 15% in controls (Ib < 0.005, relative risk 6.0) . The
frequencies of the sequences defined by the otherprobes were slightly increased in
the patients, but the differences were not statistically significant .
These data indicate that among the various sequences characterizing DR4 and
its subspecificities, the amino acid residues 70-74 of the DRBI chain defined by
probe 3 are most important in developing RA in the patients studied . The amino
acid sequence of DR4/Dw15, DR4/Dw14, and DRl alleles is Gln7°-Arg7l-Arg72_
Ala"-Ala" . If this is a real disease susceptibility sequence to RA, then all theDR
alleles that have this particular sequence should have an increasedchance ofdeveloping
RA . Previous studies generally support this possibility. In Japanese, the HLA-
DR4/Dw15 specificity (HLA-DYT) is the susceptibility factor to RA (6) . Nepom
et al . (14) found that DR4/Dw14 is significantly associated with RA in Caucasians .
Several reports have described the significant association ofDRl with RA (15, 16) .
Furthermore, Duquesnoy et al. (17) reported thatMCI, which is a supertypic specificity
associated with DR1 and a part ofDR4, is more strongly associated with RA than
DR4.
In Caucasians the association between DR4/Dw4 and RA is well established (1,
18) . The DR4/Dw4 sequence differs by only one amino acid from the particular
sequence in DR4/Dw15, DR4/Dw14, and DRl alleles : Dw4 has lysine instead of
arginine at the 71st position (Table III) . Since both amino acids are basic, this sub-
stitutiondoes not significantlychange thenet charge and may not alterthe function
of this portion .
The DRw10 has arginine at the 70th position instead of glutamine . In regard to
the net charge, this region of DRw10 is also positively charged. Therefore, DRw10
TABLE II







Probe 1 (DR4) 13 (42) 9 (27) 1 .9 NSt
Probe 2 (Dw15, DRw8) 12 (39) 8 (24) 2.0 NS
Probe 3 (Dw14, Dw15, DRl) 16 (52) 5 (15) 6.0 <0.005
Probe 4 (Dw10, DRw13) 5 (16) 2 (6) 3.0 NS
` Percent shown in parentheses .
$ NS, Not significant .2266 WATANABE ET AL. BRIEF DEFINITIVE REPORT
TABLE III
Comparison of the Amino Acids 70-74 of the DRB1 Chain
in Relation to RA Susceptibility
A hyphen indicates identity with the DR1 sequence in terms of charge and polarity.
A, acidic amino acids; B, basic amino acids; N, nonpolar amino acids ; U, uncharged
polar amino acids.
` Association of DRwl0 with RA has not yet been well established (see text).
could be associated with RA, although few association studies have been reported
thus far.
Amino acid substitutions that alter the net charge of this portion clearly affect
the RA susceptibility ofthis allele (Table III). For example, DR4/Dw10 has aspartic
acid and glutamic acid instead of glutamine and arginine at positions 70 and 71,
respectively. Inthe Israeli population, in which DR4/Dw10 isthe preponderant DR4
subtype, no association betweenDR4 andRA wasobserved(16). In the caseofDR2,
neutral glutamine at the 70th position is substituted by aspartic acid, and a neutral
or even negative association with RA has been reported (4, 7).
These findings support that the amino acid residues 70-74 of the DRB1 chain
are crucial in RA susceptibility. Thisconclusion isbasicallyconsistent with the shared
epitope hypothesis by Gregersen et al. (19). Todd et al. (20) also reached a similar
conclusion that amino acid residues 70 and 71 in particular may be important.
Of great interest is that this region of the DR molecule may participate in the
antigenbinding according to the structural modelby Brown et al. (21). It is possible
that the alteration ofcharge, polarity, or conformation in this region may affect the
interaction between the DR molecule and putative triggering agent(s) ofRAand/or
TCRs, resultinginchangesofimmuneresponsiveness tothetrigger(s)orselfmolecules.
Summary
The association between HLA-DR4 and rheumatoid arthritis (RA) has been es-
tablished in many ethnic groups. To clarify the determinant ofsusceptibility to RA,
apolymorphic segmentoftheHLA-DRB genewasamplifiedin vitro bypolymerase
chain reaction and analyzed with oligonucleotide probes specific forthe HLA-DR4
DNA sequences. A particular sequence encoding amino acids Gln7°-Arg7t-Arg72-









DR1, DR4/Dw4, DR4/Dwl4, DR4/Dw15 U B B N N
(DRw10 B _ _ _ _)"
Neutral or negative association
DR2/Dw2, DR2/Dwl2, DR5, DRw8 F,
DR2/Dw21 _ N
DR3 U B
DR4/Dw10, DRwl3 A A - - -
DR4/Dw13 A
DRwl4, DR9 B A





amino acid sequence occurs in the DRB molecules with three RA-associated
specificities, DR4/Dw14, DR4/Dw15, and DRI. DR4/Dw4, which is common in
Caucasian RA patients, has a strikingly similar amino acid sequence Gln70-Lys7l -
Arg72-Ala73-Ala74 in terms of polarity and charge profiles. Other RA nonassociated
sequences differ from this sequence by at least one amino acid substitution that causes
the change of the net charge. The composition of amino acid residues at the posi-
tions 70-74 may play a crucial role in the pathogenesis of RA.
We are grateful to Mr. Masami Itoh for his excellent technical assistance and to Dr. Shoji
Kuwata for his helpful discussion.
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